Motor Unit Number Index as a Biomarker for Spinal Muscular Atrophy

Motor Unit Number Index as a Biomarker for Spinal Muscular Atrophy

Major challenges in the clinical care of those with spinal muscular atrophy (SMA) are determining patients’ clinical stages, identifying exactly how the disease is progressing, and distinguishing SMA from other, muscular disorders. To help overcome these difficulties,...
Spinal Muscular Atrophy: Psychological Support

Spinal Muscular Atrophy: Psychological Support

Psychological support for patients and families is a critical but often neglected component of care in Spinal Muscular Atrophy (SMA).1 Families will have psychological support needs that differ depending on where they are in their respective healthcare odysseys, from...
Spinal Muscular Atrophy: Assessment of Growth and Growth Delay

Spinal Muscular Atrophy: Assessment of Growth and Growth Delay

Spinal Muscular Atrophy (SMA) is a congenital, progressive neuromuscular disease with the most common age of onset in early childhood.1 Childhood is a period of significant growth and development. While patients with some forms of SMA (type 0 and 1) will experience...